Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial
暂无分享,去创建一个
Eric E. Smith | S. Connolly | S. Messé | B. Yoon | Mukul Sharma | A. Shoamanesh | S. Coutts | S. Berkowitz | R. Hart | B. Modrau | J. Lambeck | S. Ameriso | J. Rha | L. Pearce | D. Damgaard | H. Mundl | M. Romano | K. Perera | J. Barlinn | F. Saad
[1] S. Connolly,et al. Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial. , 2020, JAMA neurology.
[2] Thalia Shoshana Field,et al. Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke , 2020, Stroke.
[3] R. Sacco,et al. Classification of Covert Brain Infarct Subtype and Risk of Death and Vascular Events. , 2019, Stroke.
[4] H. Kamel,et al. Tailoring the Approach to Embolic Stroke of Undetermined Source: A Review. , 2019, JAMA neurology.
[5] S. Connolly,et al. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[6] D. Tanné,et al. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. , 2018, The Lancet. Neurology.
[7] P. Rothwell,et al. Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis , 2018, The Lancet Neurology.
[8] S. Connolly,et al. Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial. , 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[9] S. Connolly,et al. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source , 2018, The New England journal of medicine.
[10] K. Hirao,et al. Incidence of silent cerebral infarctions after catheter ablation of atrial fibrillation utilizing the second-generation cryoballoon , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[11] S. Connolly,et al. Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update , 2017, Stroke.
[12] Eric E. Smith,et al. Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2017, Stroke.
[13] J. Pogue,et al. Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial , 2016, European stroke journal.
[14] S. Connolly,et al. Embolic strokes of undetermined source: the case for a new clinical construct , 2014, The Lancet Neurology.
[15] D. Inzitari,et al. Variation in Risk Factors for Recent Small Subcortical Infarcts With Infarct Size, Shape, and Location , 2013, Stroke.
[16] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[17] R. D'Agostino,et al. Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study , 2008, Stroke.
[18] P. Koudstaal,et al. Silent brain infarcts: a systematic review , 2007, The Lancet Neurology.